URN:NBN:SI:doc-AQ6A9UT92022Vrbovšek, Lidijadocuments/doc/A/URN_NBN_SI_doc-AQ6A9UT9_001.pdfdocuments/doc/A/URN_NBN_SI_doc-AQ6A9UT9_001.txt473articlestr. 313-3201413565472536-4316URN:NBN:SI:doc-AQ6A9UT9slvSlovensko farmacevtsko društvoFarmacevtski vestnikInCextemporaneously prepared medicinesmagistralno zdraviloobvladovanje tveganjocena tveganjaResolucija CM/ResAP(2016)1Resolution CM/ResAP(2016)1risk assessmentrisk managementOcena tveganja za magistralna zdravilaRisk assessment for extemporaneously prepared medicines